Affiliation:
1. Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Science
2. Novosibirsk Oncological Hospital
3. A.I. Evdokimov Moscow State University of Medicine and Dentistry
4. Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Science; Nizhnevartovsk Oncological Hospital
Abstract
Background.Currently, the indications for multivisceral pelvic resections have increased dramatically. However, short-and long-term outcomes after these resections for locally advanced rectal cancer remain a subject of debate.The purposeof the study was to evaluate short-term surgical and oncological outcomes after multivisceral pelvic resections in patients with locally advanced rectal cancer.Material and methods. We analyzed surgical outcomes in 32 patients (13 men and 19 women) aged 44-69 years, with locally advanced rectal cancer, who were treated between 2010 and 2016. Of the 32 patients, 28 (87.5 %) had rectal cancer with invasion into adjacent organs (posterior wall of the bladder - 13, uterus - 10, ureters - 5, prostate - 4, vagina - 3; simultaneous damage to more than 2 organs - 14, multiple primary malignant tumors: rectal cancer + bladder cancer - 2, rectal cancer + endometrial cancer - 1, rectal cancer + rectal GIST - 1.Results.Total pelvic evisceration was performed in 6 (18.8 %) cases, combined resection of the rectum and adjacent organs was performed in 26 (81.2 %). Urinary tract resection was performed in 24 (75.0 %) patients. Of these patients, 13 (40.6 %) had primary plasty of the bladder and/or ureters. Postoperative surgical complications were observed in 11 (34.4 %) patients, of whom 7 (21.8 %) patients needed re-surgery. In 1 patient (3.1 %), who died in the early postoperative period, the cause of death was thrombosis of the right iliac vessels with subsequent acute renal failure. For patients with locally advanced rectal cancer, long-term outcomes were as follows: the overall and recurrence-free 2-year survival rates were 75 % and 56.3 %, respectively. All patients with multiple primary malignant tumors were alive with no evidence of disease recurrence at a follow-up of >24 months.Conclusion.Multivisceral resection in patients with locally advanced rectal cancer is a complex surgical procedure requiring the multidisciplinary team of surgeons. Despite high operative morbidity, proper perioperative management of the patients helps to achieve satisfactory immediate treatment outcomes. Long-term outcomes allowed us to consider such resections as a method of choice for locally advanced and multiple primary rectal cancers.
Publisher
Tomsk Cancer Research Institute
Reference24 articles.
1. Bray F, Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68 (6): 394-424. doi: 10.3322/caac.21492.
2. Kaprin A.D., Starinsky V.V., Petrova G.V Status of oncological care for the population of Russia in 2016. Moscow, 2016. 236. (in Russian).
3. Kalinin E.V, Antipova S.V, KalininA.E. Possibilities of surgical treatment in patients with locally advanced rectal cancer with involvement of the posterior urinary bladder wall. Colorectal oncology. 2012; 1: 18-24. (in Russian).
4. Aglullin I.R., Didakunan F.I., Zigan-shin M.I., Valiev A.A., Aglullin T.I., Safin I.R., Aglullin M.I. Technical aspects of evisceration pelvis organs Oncology. Bulletin of the Volga region. 2015; 4: 63-69. (in Russian).
5. UsovaA.V, FrolovaI.G., AfanasyevS.G., TarasovaA.S. Potential role of magnetic resonance imaging in diagnosis and assessment of treatment response in patients with rectal cancer. Siberian Journal of Oncology. 2012; 5: 74-80. (in Russian).